Author

J.-C. Bories

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Domenger· 1 shared B. Arnulf· 1 shared C. Choisy· 1 shared C. Demangel· 1 shared G. Dadaglio· 1 shared L. Baron· 1 shared L. Deriano· 1 shared V. Mayau· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Domenger

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivSep 5, 2021

The Sec61 translocon is a therapeutic vulnerability in Multiple Myeloma

A. Domenger, C. Choisy, L. Baron…·C. Demangel

This study shows that targeting the Sec61 translocon with mycolactone enhances the effectiveness of bortezomib in killing multiple myeloma cells and reduces toxicity.

DOI 10.15252/emmm.202114740

humanbulk RNA-seq

𝕏 PostBluesky